Page 279 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 279

CM-12


               Isolation,  structural  characterization,  and  anti-dengue  virus  activity  of

               constituents from Lycii Radicis Cortex


                                               1
                                                                   1
                            #,1
               Yi-Ting Sun,  Wen-Xuan Pan,  Cheng-Ming Tsai,  Sio-Hong Lam*         ,1,2

               1  School of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University,
                 Tainan, 701401, Taiwan
               2  School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701401,
                 Taiwan
               * E-mail: shlam@mail.ncku.edu.tw

               Abstract
                  Dengue  fever  is  widely  prevalent  in  tropical  and  subtropical  regions,  with Asia,  Latin
               America, and Africa being as high-risk areas. In Taiwan, dengue fever is primarily caused by
               dengue virus serotype 2 (DENV-2), with outbreaks most frequently occurring in the southern
               regions. Despite being a major global public health concern, there are currently no effective
               antiviral drugs available for dengue fever. Regarding vaccines, Dengvaxia and Qdenga have
               been approved for use under specific conditions; however, their applicability and safety still
               require further evaluation and improvement. Lycii Radicis Cortex (LRC) is a commonly used
               herbal  remedy  derived  from  the  root  bark  of  Lycium  chinense  or  Lycium  barbarum,  both
               belonging to the family Solanaceae. Traditionally, it is used for clearing heat, cooling the blood,
               and relieving internal heat symptoms, such as tidal fever due to yin deficiency, night sweats,
               lung heat cough, hemoptysis, and various forms of non-traumatic bleeding. Preliminary studies
               revealed  that  the  methanolic  extract  of  LRC  exhibited  moderate  antiviral  activity  against
               DENV-2, with inhibition rates of 25.6% at 25 µg/mL and 74.7% at 50 µg/mL. Subsequent
               solvent partitioning of the methanol extract yielded an n-butanol layer and an aqueous layer.
               The n-butanol layer showed a higher inhibition rate (44.4% at 25 µg/mL) than the crude extract,
               indicating  enrichment  of  the  active  components  in  this  fraction.  Ongoing  research  aims  to
               isolate active compounds from LRC using chromatographic techniques, including silica gel
               column chromatography, Sephadex LH-20, and high-performance liquid chromatography. To
               date, nine compounds have been isolated and identified from the n-butanol fraction of LRC,
               comprising one coumarin, one flavonoid, four phenylpropanoids, one benzoic acid, one steroid,
               and  one  lipid.  The  chemical  structures  of  these  compounds  will  be  elucidated  through
               spectroscopic analyses, and their antiviral activities against dengue virus will be evaluated,
               along with investigations into their underlying mechanisms of action.

               Keywords: Lycii Radicis Cortex; Anti-dengue virus; DENV-2; Traditional Chinese Medicine
   274   275   276   277   278   279   280   281   282   283   284